We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Current-Tunneling Measurements Analyze Single DNA Molecules

By LabMedica International staff writers
Posted on 09 Jul 2018
A team of Japanese genomics researchers has devised a method for cancer diagnosis, which is based on the analysis of single molecules of DNA without the need for chemical modification or amplification.

Cancer can be diagnosed by identifying DNA and microRNA base sequences that have the same base length yet differ in a few base sequences, if the abundance ratios of these slightly deviant base sequences can be determined. More...
However, such quantitative analyses cannot be performed using the current DNA sequencers.

In this regard, investigators at Osaka University (Japan) used current-tunneling measurements to determine the entire base sequences of four types of DNA corresponding to the let-7 microRNA, which is a 22-base cancer marker.

The tunneling currents flowing through single molecules were measured by gold electrodes – maintained at a distance of 0.75 nanometers from each other, equivalent to the size of a DNA base molecule – using a mechanically controllable break-junction. Single-molecule signals were obtained in forms of current spikes, whose height represented the electron transport through the molecule. Since this method measured single molecules, it did not require chemical modification of DNA or amplification by PCR.

As the method measured individual DNA molecules, two or more base sequences could be determined by measuring a solution of DNA molecules with two or more types of base sequences. Furthermore, since this method could count the number of DNA molecules that contained a specific base sequence, quantitative analysis could detect the base sequences and determine their frequency.

"Because the single-molecule sequencing method detects differences in the electronic states of molecules in terms of single-molecule conductances, it may also be applied to the analysis of microRNA and RNA molecules that include four base molecules and peptides that include 20 kinds of amino acids," said senior author Dr. Masateru Taniguchi, a professor in the institute of scientific and industrial research at Osaka University. "Also, as the method can detect chemically modified base molecules and amino acids, it represents a substantive step toward realizing personalized genomic diagnosis of cancer and other diseases."

The current-tunneling method was described in a paper published in the June 4, 2018, online edition of the journal Scientific Reports.

Related Links:
Osaka University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Urine Chemistry Control
Dropper Urine Chemistry Control
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.